Home›Screener›BIIB›Profile

D

36/100

Biogen Inc

BIIBNeuroscience

← Signals View

📋

Analyst Summary

✓ VERIFIED2026-04-11

Biogen Inc (BIIB) is the lead sponsor of 39 active clinical trials listed on ClinicalTrials.gov^[5], including 15 Phase 3^[1], 4 Phase 2^[2], 7 Phase 1^[3], 1 Phase 4^[4].

Trial NCT03958877^[6] evaluates BIIB017 (peginterferon beta-1a) in Multiple Sclerosis, Relapsing-Remitting with a target enrollment of 152 participants. Trial NCT06953583^[7] evaluates Omaveloxolone in Friedreich Ataxia with a target enrollment of 255 participants. Trial NCT04961567^[8] evaluates Litifilimab in Lupus Erythematosus, Systemic with a target enrollment of 562 participants.

BIIB has 1 Form 4 insider filing recorded at the SEC in the past 30 days^[9].

Sources

ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov · NCT03958877 (2025-09-11) ↗
ClinicalTrials.gov · NCT06953583 (2026-03-16) ↗
ClinicalTrials.gov · NCT04961567 (2026-01-29) ↗
SEC EDGAR · 0000875045 (2026-04-11) ↗

🏛

Upcoming Catalysts

lecanemab (Leqembi) — early AD subcutaneous sNDA

2026-12-10

in 189d

🔬

Clinical Trials

39

NCT03584165Choroideremia, X-Linked Retinitis Pigmentosa

clinicaltrials_gov · Retrieved 2026-04-11

NCT03958877Multiple Sclerosis, Relapsing-Remitting

clinicaltrials_gov · Retrieved 2026-04-11

NCT04317794Muscular Atrophy, Spinal

clinicaltrials_gov · Retrieved 2026-04-11

NCT04729907Muscular Atrophy, Spinal

clinicaltrials_gov · Retrieved 2026-04-11

NCT04856982Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation

clinicaltrials_gov · Retrieved 2026-04-11

NCT04895241Lupus Erythematosus, Systemic

clinicaltrials_gov · Retrieved 2026-04-11

NCT04961567Lupus Erythematosus, Systemic

clinicaltrials_gov · Retrieved 2026-04-11

NCT05042921Muscular Atrophy, Spinal

clinicaltrials_gov · Retrieved 2026-04-11

NCT05067790Spinal Muscular Atrophy

clinicaltrials_gov · Retrieved 2026-04-11

NCT05348785Parkinson Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT05352919Systemic Lupus Erythematosus (SLE)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05399888Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia

clinicaltrials_gov · Retrieved 2026-04-11

NCT05531565Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus

clinicaltrials_gov · Retrieved 2026-04-11

NCT05575011Healthy Volunteer, Muscular Atrophy, Spinal

clinicaltrials_gov · Retrieved 2026-04-11

NCT05618379Muscular Atrophy, Spinal

clinicaltrials_gov · Retrieved 2026-04-11

NCT05658497Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05688436Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05767736Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05789758Muscular Atrophy, Spinal

clinicaltrials_gov · Retrieved 2026-04-11

NCT05925049Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06044337Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus

clinicaltrials_gov · Retrieved 2026-04-11

NCT06054893Friedreich Ataxia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06064929Lupus Nephritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06555419Muscular Atrophy, Spinal

clinicaltrials_gov · Retrieved 2026-04-11

NCT06623890Friedreich Ataxia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06628687Friedreich Ataxia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06685757Antibody-mediated Rejection

clinicaltrials_gov · Retrieved 2026-04-11

NCT06935357Immunoglobulin A Nephropathy (IgAN)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06953583Friedreich Ataxia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06962800Primary Membranous Nephropathy

clinicaltrials_gov · Retrieved 2026-04-11

NCT07047820Depression, Postpartum

clinicaltrials_gov · Retrieved 2026-04-11

NCT07133828Healthy Volunteer

clinicaltrials_gov · Retrieved 2026-04-11

NCT07219043Microvascular Inflammation

clinicaltrials_gov · Retrieved 2026-04-11

NCT07221669Muscular Atrophy, Spinal

clinicaltrials_gov · Retrieved 2026-04-11

NCT07223723Amyotrophic Lateral Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT07225517Healthy Volunteer

clinicaltrials_gov · Retrieved 2026-04-11

NCT07259980Amyotrophic Lateral Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT07297199Healthy Volunteer

clinicaltrials_gov · Retrieved 2026-04-11

NCT07398469Postpartum Depression

clinicaltrials_gov · Retrieved 2026-04-11

👤

Insider Activity

1

1 filing

sec_edgar · Retrieved 2026-04-11

Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.

Score Breakdown

Score Trend

2026-04-132026-06-02

Signal Summary

PDUFA Dates1

Insider Filings1

Clinical Trials1

Sector Peers (Neuroscience)

SAVACassava Sciences

A

HRMYHarmony Biosciences

A

DNLIDenali Therapeutics

C

SAGESage Therapeutics

C

NBIXNeurocrine Biosciences

Data Provenance

cik1 verified

clinical trial39 verified

insider buy1 verified

trial count5 verified

Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR